BMC Oral Health | |
Trehalose versus carboxymethylcellulose oral spray for relieving radiation-induced xerostomia in head and neck cancer patients: a randomized controlled trial | |
Research | |
Joao N. Ferreira1  Khwanchanok Maison2  Thirayu Boonroung3  Jeerus Sucharitakul4  Pornpan Piboonratanakit5  Ganokon Urkasemsin6  Anussara Prayongrat7  Chawalit Lertbutsayanukul7  Kulpriya Pravinvongvuthi8  Anjalee Vacharaksa9  | |
[1] Avatar Biotechnologies for Oral Health and Healthy Longevity Research Unit, Department of Research Affairs, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand;Avatar Biotechnologies for Oral Health and Healthy Longevity Research Unit, Department of Research Affairs, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand;Department of Preclinic and Applied Animal Science, Faculty of Veterinary Science, Mahidol University, Bangkok, Thailand;Dental Department, King Chulalongkorn Memorial Hospital, Bangkok, Thailand;Department of Biochemistry, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand;Department of Oral Medicine, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand;Research Unit in Oral Diseases, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand;Department of Preclinic and Applied Animal Science, Faculty of Veterinary Science, Mahidol University, Bangkok, Thailand;Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;Geriatric and Special Patients (International) Program, Faculty of Dentistry, Chulalongkorn University, 34 Henri-Dunant Road, Pathumwan, 10330, Bangkok, Thailand;Geriatric and Special Patients (International) Program, Faculty of Dentistry, Chulalongkorn University, 34 Henri-Dunant Road, Pathumwan, 10330, Bangkok, Thailand;Department of Microbiology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand;Excellent Center on Microbiology and Immunology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand; | |
关键词: Head and neck cancer; Radiotherapy; Salivary gland; Hyposalivation; Xerostomia; Trehalose; | |
DOI : 10.1186/s12903-023-02966-4 | |
received in 2022-11-17, accepted in 2023-04-15, 发布年份 2023 | |
来源: Springer | |
【 摘 要 】
BackgroundThe aim of this study was to investigate the effect of trehalose oral spray to relieve radiation-induced xerostomia on a randomized controlled trial (RCT).MethodsPrior to RCT, the effect of trehalose (5–20%) on the epithelial growth of fetal mouse salivary gland (SG) explants was evaluated to confirm if 10% trehalose exerted the best epithelial outcomes. Participants who completed radiotherapy for head and neck cancer (HNC) treatment were enrolled in a double-blind RCT, according to inclusion and exclusion criteria as per the CONSORT statement. The experimental group (n = 35) received 10% trehalose spray, while the control group (n = 35) received carboxymethylcellulose (CMC) spray to apply intra-orally 4 times/day for 14 days. Salivary pH and unstimulated salivary flow rate were recorded pre- and post-interventions. The Xerostomia-related Quality of Life scale (XeQoLs) was filled, and scores assessed post-interventions.ResultsIn the SG explant model, pro-acinar epithelial growth and mitosis was supported by 10% topical trehalose. As for RCT outcomes, salivary pH and unstimulated salivary flow rate were significantly improved after use of 10% trehalose spray when compared to CMC (p < 0.05). Participants reported an improvement of XeQoLs dimension scores after using trehalose or CMC oral sprays in terms of physical, pain/discomfort, and psychological dimensions (p < 0.05), but not social (p > 0.05). When comparing between CMC and trehalose sprays, XeQoLs total scores were not statistically different (p > 0.05).ConclusionsThe 10% trehalose spray improved salivary pH, unstimulated salivary flow rate, and the quality-of-life dimensions linked with physical, pain/discomfort, and psychological signs. The clinical efficacy of 10% trehalose spray was equivalent with CMC-based saliva substitutes for relieving radiation-induced xerostomia; therefore, trehalose may be suggested in alternative to CMC-based oral spray.(Thai Clinical Trials Registry; https://www.thaiclinicaltrials.org/ TCTR20190817004).
【 授权许可】
CC BY
© The Author(s) 2023
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202308152322793ZK.pdf | 1213KB | download | |
41116_2023_36_Article_IEq434.gif | 1KB | Image | download |
【 图 表 】
41116_2023_36_Article_IEq434.gif
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]